2m 2m 2m 2m 2m 2m 2m
DARE BIO (DARE)
NASDAQ
$2.00-$0.15 (-6.78%)
Price as of Jun 03, 2026 6:40 PM EDT- $33.4MMarket Cap
- -30.74%1-Year Change
- BiotechnologyIndustry
DARE BIO (DARE)
$2.00-$0.15 (-6.78%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.0M N/A | 0 -100.00% | 2.8M -71.92% | 10.0M N/A | |
Cost of Revenue | 295,799 N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 734,394 N/A | 0 -100.00% | 2.8M -71.92% | 10.0M N/A | |
Sales and Marketing Expense | 8.8M N/A | N/A N/A | N/A N/A | 5.4M 0.00% | |
Research and Development Expense | -5.5M -61.12% | -14.2M -34.05% | -21.5M -28.31% | -30.0M -1.88% | |
Depreciation and Amortization Expense | 1.6M +3,761.75% | 42,325 +10.33% | 38,363 +58.51% | 24,202 -8.37% | |
Total Operating Expenses | 14.3M -39.11% | 23.5M -30.48% | 33.7M -18.46% | 41.4M +5.93% | |
Operating Profit | -13.6M -42.21% | -23.5M -24.20% | -30.9M -1.42% | -31.4M -19.67% | |
Interest Income | 679,740 +25.94% | 539,743 N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 679,740 +25.94% | 539,743 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | -153,060 -84.41% | -981,490 -226.08% | 778,489 +77.84% | 437,750 +17,271.03% | |
Income before Taxes | -13.4M +230.55% | -4.1M -86.56% | -30.2M -2.54% | -30.9M -20.02% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -13.4M +230.55% | -4.1M -86.56% | -30.2M -2.54% | -30.9M -20.02% | |
Net Income from Continuing Operations Applicable to Common | -13.4M +230.55% | -4.1M -86.56% | -30.2M -2.54% | -30.9M -20.02% | |
Basic EPS and Net Income | -1.20 +150.00% | -0.48 +37.14% | -0.35 -5.41% | -0.37 -41.27% | |
Diluted EPS and Net Income | -1.20 +150.00% | -0.48 +37.14% | -0.35 -5.41% | -0.37 -41.27% | |
Basic Weighted Average Shares | 11.2M +31.55% | 8.5M -90.27% | 87.3M +3.23% | 84.6M +38.29% | |
Diluted Weighted Average Shares | 11.2M +31.55% | 8.5M -90.27% | 87.3M +3.23% | 84.6M +38.29% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 24.7M +57.42% | 15.7M +49.85% | 10.5M -69.78% | 34.7M -32.91% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 24.7M +57.42% | 15.7M +49.85% | 10.5M -69.78% | 34.7M -32.91% | |
Total Current Assets | 27.1M +46.70% | 18.4M +5.15% | 17.5M -59.24% | 43.0M -22.17% | |
Accumulated Depreciation | 338,013 +92.17% | 175,894 N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.6M +16.71% | 1.3M +103.63% | 655,975 +910.62% | 64,908 +149.25% | |
Total Long-Term Assets | 1.0M -8.11% | 1.1M +83.22% | 599,594 -17.04% | 722,722 +48.98% | |
Total Assets | 32.5M +46.94% | 22.1M +3.85% | 21.3M -51.44% | 43.8M -21.47% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 23.7M +9.61% | 21.6M +5.51% | 20.5M -35.24% | 31.6M +97.00% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 559,365 -68.12% | 1.8M -9.37% | 1.9M +77.53% | 1.1M N/A | |
Total Liabilities | 29.6M +5.40% | 28.1M +6.77% | 26.3M -19.52% | 32.7M +91.84% | |
Retained Earnings | -188.7M +7.64% | -175.3M +2.37% | -171.2M +21.38% | -141.1M +28.10% | |
Total Stockholders Equity | 2.8M +147.28% | -6.0M +19.11% | -5.0M -145.42% | 11.1M -71.33% | |
Total Shares Outstanding | 14.5M +66.65% | 8.7M -91.30% | 100.0M +17.86% | 84.8M +1.05% | |
Cash Flow | |||||
Cash from Operating Activities | -9.9M -283.27% | 5.4M +113.88% | -38.9M +114.81% | -18.1M -37.11% | |
Capital Expenditures | 385,278 -32.77% | 573,046 -8.96% | 629,430 +898.00% | 63,069 +334.24% | |
Cash from Investing Activities | -385,278 -32.77% | -573,046 -8.96% | -629,430 +898.00% | -63,069 +334.24% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 19.3M +4,343.48% | 433,830 -97.23% | 15.6M +1,064.04% | 1.3M -98.23% | |
Financials Ratio | |||||
Gross Margin | 71.29% N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,315.51% N/A | N/A N/A | -1,101.89% +251.08% | -313.85% N/A | |
Return on Assets | -49.10% +162.76% | -18.69% -79.83% | -92.65% +49.14% | -62.12% -49.14% | |
Return on Equity | 845.53% +1,053.45% | 73.30% +107.37% | -994.69% +701.38% | -124.12% -39.69% | |
Revenue Growth | N/A N/A | -100.00% +39.04% | -71.92% N/A | N/A N/A | |
Current Ratio | 1.14 +33.84% | 0.85 -0.34% | 0.86 -37.06% | 1.36 -60.49% | |
Cash Ratio | 1.04 +43.61% | 0.73 +42.03% | 0.51 -53.34% | 1.10 -65.94% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow